Elevation Oncology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ELEV and buy or sell other stocks, ETFs, and their options commission-free!

About ELEV

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. 

CEO
Kevin C. Tang
CEOKevin C. Tang
Employees
34
Employees34
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2019
Founded2019
Employees
34
Employees34

ELEV Key Statistics

Market cap
21.62M
Market cap21.62M
Price-Earnings ratio
-0.45
Price-Earnings ratio-0.45
Dividend yield
Dividend yield
Average volume
575.88K
Average volume575.88K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$2.26
52 Week high$2.26
52 Week low
$0.221
52 Week low$0.221

People also own

Based on the portfolios of people who own ELEV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.